Psilocybin is a serotonin receptor agonist that occurs naturally in some fungal species. Recent studies have evaluated the therapeutic potential of psilocybin for a variety of conditions, including end-of-life anxiety, obsessive-compulsive disorder, smoking, and alcohol dependence with promising preliminary results.
Psilocybin can cure severe depression quickly and safely, so take note.
A hallucinogenic chemical found in magic mushrooms has managed to eliminate severe depression in previously incurable patients. Scientists at Imperial College London induced intense psychedelic trips in 12 people who used high doses of the banned substance psilocybin.
One week after the experiment, all volunteers were free of depression, and three months later five had no symptoms of the disease. Psilocybin is believed to cause depression relief by targeting receptors in the brain and disrupting the neural network by default, which is responsible for the sense of self and is overactive in depressed people.
Psilocybin, present in magic mushrooms, cures depression in a single dose.
Psilocybin, which is found in magic mushrooms, was given to depressed patients in a pill.
Psilocybin mushrooms can cure severe depression naturally
However, the scientists did not rule out that the psychedelic trip could have caused an “awakening,” of the kind attained by spiritual teachings, which also helped to eliminate depression.
Despite promising results, researchers urged people not to test magic mushrooms themselves as a cure for depression.
Lead author of the study Dr. Robin Carhart-Harris said:
Psychedelic drugs have potent psychological effects and are only administered in our research when there are adequate safeguards, such as careful selection and professional therapeutic support.
I do not want members of the public to think that they can treat their own depressions by choosing their own magic mushrooms. That kind of approach could be risky.
The volunteers from the trial were given psilocybin orally in capsules and were then monitored closely.
“Our study has shown that psilocybin is safe and quick-acting, so it can, if carefully administered, have value for these patients,” says Professor David Nutt, who participated in the research.
Amanda Feiling, of the Beckley Foundation, who also participated in the research, said: “For the first time in many years, people who were at the end of the road with currently available treatments reported decreased anxiety, increased optimism and a capacity To enjoy things.
“This is an unprecedented success and could revolutionize the treatment of depression.”